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In the realm of materials chemistry, selective repetitive incorporation of prochiral monomers
is used to prepare production-scale quantities of stereochemically defined polymers. Chiral
natural products such as polyketides, oligosaccharides, and peptides feature repeating subunits,
but the application of controlled oligomerization for the concurrent creation of carbon skeletal
frameworks and tetrahedral stereochemistry is an undeveloped tactic in total synthesis (Fig.
1).1 The zaragozic acids – picomolar inhibitors of the enzyme catalyzing the first committed
step in the production of cholesterol2,3 and compounds that potentiate radiochemotherapy in
the destruction of acute myeloid leukemia (AML) cell lines4 – provide the context for the
development and implementation of a new synthetic strategy that reduces this idea to practice.
This report discloses the conceptual framework and experimental details for a short synthesis
of zaragozic acid C (1). The brevity of the sequence described herein is the consequence of a
heretofore unprecedented stereoselective oligomerization reaction and adherence to a synthetic
plan predicated on the minimization of oxidation state variance and protecting group
manipulation.
The highly oxygenated 2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid core of
zaragozic acid C features six contiguous asymmetric centers that comprise the principal
obstacle to synthesis. The two fully substituted hydroxy acids at C4 and C5 in the hydrated
acyclic precursor 2 have been particularly nettlesome in extant syntheses5,6 and commonly
require multistep oxidation state, functional group, and/or protecting group adjustment. What
we found striking about zaragozic acid C was that the global complexity masks a rather
elementary composition of simple building blocks. A retrosynthetic analysis of zaragozic acid
C through bond disconnection into its constituent synthons (Fig. 2, blue arrows) reveals a
repeating series of glycolic acid fragments.
In contemplating efficient connections that would enable the rapid construction of 2 or its
equivalent, we were compelled to consider a “self-consistent sequence,” one that concurrently
merges carbon skeletal buildup with the introduction of stereochemistry, as a method that
would be uniquely efficient.7,8 Thus, a self-consistent synthesis of the zaragozic acid core
would be one with connection of the glycolic acid subunits in the correct relative configuration
(red arrows). The successful implementation of this strategy requires a synthetic equivalent to
the unusual geminal dipolar glycolic acid synthon 3. We recently developed the silyl glyoxylate
4 to function as a reagent for the geminal grafting of complementary nucleophilic and
electrophilic reagents onto a protected glycolic acid.9–11 The reactivity pattern exhibited by
4 is summarized in Fig. 3. Nucleophilic attack on the silyl glyoxylate facilitates C→O silicon
migration (Brook rearrangement)12 to form a stabilized carbanion. This nascent enolate reacts
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Given the retrosynthetic analysis presented in Fig. 2 and the surrogacy of 4 for 3, we tested the
hypothesis that enchainment of >1 equivalent of 4 could be used to assemble the zaragozic
acid backbone in one step. The addition of one equivalent of vinylmagnesium bromide to two
equivalents of 4 at −78 °C initiated the oligomerization detailed in Scheme 1. The initial adduct
rearranged to provide a new carbon nucleophile that enchained a second equivalent of 4. A
second Brook rearrangement delivered the second magnesium enolate of the cascade. The
sequence was terminated via the introduction of tert-butyl glyoxylate (6). The α-hydroxy ester
7 was obtained in 45–50% yield on a 15 g scale as one diastereomer, the structure of which
was determined from an X-ray diffraction study.13,14 Three contiguous stereogenic centers
of the carbon skeleton were assembled in the correct oxidation state. The direct delivery of the
needed functional array meant that no oxidation state adjustment was required in this domain
for the remainder of the synthesis. Beyond the native efficiency issues, this attribute was
unexpectedly critical for the successful completion of the synthesis (vide infra). Moreover, the
reaction achieved its secondary design purpose of providing an ideal protecting group scheme
that masked every functional group except the secondary alcohol that would participate in the
subsequent reaction. The product obtained possessed the correct relative stereochemistry for
the challenging C4 and C5 tertiary alcohols, while the stereocenter that would eventually
become C3 of the core required inversion. Epimerization of 7 with 1,8-diazabicyclo[5.4.0]
undec-7-ene (DBU) was possible at this stage (eq 1), but multiple downstream operations were
unsuccessful with epi-7. For this reason, compound 7 bearing the incorrect C3 configuration
was advanced with the expectation that it could be rectified later in the synthesis.
(1)
The racemic α-hydroxy ester (±)-7 was subjected to a vanadium-catalyzed oxidative kinetic
resolution using O2 as the stoichiometric oxidant (Scheme 2).15 The resolution yielded 48%
(of a maximum 50%) of (−)-7 with an enantiomer ratio (er) of 90:10. In anticipation of a
projected intramolecular aldol reaction to introduce the C6/C7 diol, the C3 hydroxyl group was
converted to its derived ester 9 with α-benzyloxyacetyl chloride. Neither the resolution nor the
acylation was successful with epi-7. The requisite C6 electrophile was then revealed through
ozonolysis of the vinyl group to provide aldehyde 10.
A completely diastereoselective intramolecular aldol reaction under carefully prescribed
conditions fashioned the C6–C7 bond and led to ε-lactone 11. Aldolization to form ε-lactones
is unusual16,17 and this case may be assisted by the high level of substitution in the connecting
carbon atoms.18 The ring closure is proposed to proceed via the illustrated transition structure
(based on the X-ray diffraction study of 11) and gives the correct stereochemistry at C7 but
the incorrect configuration at C6. Epimerization of 11 was possible to correct the C3
stereochemistry at this stage, but once again the correct C3 epimer was found to be unsuitable
in subsequent manipulations.
The C1 side chain was appended by means of a nucleophilic addition of the organolithium
1219 to the ε-lactone 11. The resulting lactol/ketol mixture (13) was treated with p-
toluenesulfonic acid in methanol, affording three products that were easily converged to the
desired tricyclic ketal 14. In addition to 14 (~10–15%), the acid-catalyzed ketalization yielded
a tricyclic lactone lacking the C4 silyl protecting group (~45–55%) and an unidentified
Nicewicz et al. Page 2













isomeric ketal (~15–20%). Resubmission of the isomeric ketal to the TsOH/MeOH conditions,
combination with the unprotected tricyclic lactone, and silylation of the C4 hydroxyl group
provided an acceptable combined yield of 14.
The presence of the δ-lactone in 14 highlights the remaining stereochemical problem: the
incorrect configurations at C6 and C3. The lactone was opened under unusual but uniquely
effective conditions (potassium tert-butoxide in tert-amyl alcohol) and surprisingly occurred
with concomitant inversion of the C6 stereocenter.20 A retro-aldol/aldol sequence is the
probable mechanism accounting for this fortuitous stereochemical correction,21 the
occurrence of which would have been impossible in the absence of functional groups in the
correct oxidation state. The reaction conditions resulted in partial saponification of the methyl
esters necessitating re-esterification with isourea 15.22 Epimerization of the inconsequential
mixture of esters (16) with NaOMe in MeOH achieved the desired configuration of the C3
stereocenter. All of the ester groups were unexpectedly cleaved in this reaction; re-esterification
of the resulting triacid using 15 gave the fully functionalized zaragozic acid core 17 with the
required stereochemistry.
Our synthesis differentiates the C6 and C7 alcohols in the key intermediate 17, but installation
of the C6 acyl side chain rendered subsequent debenzylation impracticable in our hands.
Instead, debenzylation and acetylation were achieved under standard conditions to give the
triacetate 18, a compound utilized by Carreira in the total synthesis of zaragozic acid C.5a,b
The analytical data were in full accord with those reported (1H NMR in CDCl3 and 13C NMR
in both CD3OD5b and CDCl3,5r IR, TLC, sign of rotation). The preparation of 18 thus
constitutes a formal synthesis of zaragozic acid C. As illustrated in Scheme 2, we applied the
Carreira protocol to complete the synthesis of zaragozic acid C (1) in four steps from triacetate
18. The synthetic material was identical to a sample of natural material.
The zaragozic acid C synthesis was achieved with concurrent creation of the carbon skeleton
and tetrahedral stereochemistry with only one oxidation state change (alkene ozonolysis) and
no functional group repair in the core synthesis. This study further highlights the utility of silyl
glyoxylates as geminal dipolar glycolic acid synthons. Considering the ubiquity of this
functional group in organic chemistry, the applicability of reagents like 4 for a range of efficient
molecular constructions appears promising. More broadly, given the common occurrence of
natural products that contain repeating subunits, the concept of controlled oligomerization
could have significant ramifications in small molecule synthesis. The development of new
reagents and attendant synthetic strategy will be required for the full realization of this potential,
but the chemistry described herein provides a working blueprint for such tactics.
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Silyl glyoxylate as a glycolic acid synthon.
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